We show that TREM1 myeloid-derived cytokines IL1 and OSM activate the inflammatory NF-κB family of transcription factors within the BIT tumor epithelium and lower the sensitivity of human BCC explant tumors to SMOi treatment, conferring resistance. Here, IL1A is linked to skin basal cell carcinoma.